National Institutes of Health (NIH) — 2018 Investments
254 investments dated 2018 · page 1 of 2 · listed companies and verified rows first · show all
Aethlon Medical develops the Hemopurifier, a clinical-stage extracorporeal device that uses lectin-based technology to remove extracellular vesicles and enveloped viruses from blood plasma, with current clinical programs targeting patients with advanced cancer resistant to immunotherapy and potential applications in life-threatening viral infections.
BiotechSan Diego, US
Richard H. Tullis(Executive Officer, Director)James B. Frakes(Executive Officer, Director)Rodney S. Kenley(Executive Officer, Director)James Joyce(Executive Officer, Director)inSteven P. LaRosa(Chief Medical Officer)inRICHARD H. TULLIS, PhD(Executive Officer)
Beta Bionics develops the iLet Bionic Pancreas System, an insulin delivery device for people with type 1 diabetes aged 6 and older that requires a physician's prescription.
Digital HealthHealthtechMedical DevicesIrvine, US
Edward Damiano(Executive Officer, Director)Sean Saint(President, Chief Executive Officer and Director)inStephen Feider(Chief Financial Officer)inMike Mensinger(Chief Product Officer)inSteven Russell(Chief Medical Officer)inMark Hopman(Chief Commercial Officer)in
Co-investorsLifeSci Venture PartnersWellington ManagementOmega FundsRTW Investments L.P.Soleus Capital
BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Oguzhan Atay(Founder)inDavid Tsao(CTO)inSukrit Silas(Founder)inBrett Huff(Director of Engineering)Mihir Sewak(Software Engineering Manager)Jen Katzburg(Principal Recruiter)
Co-investors500 Emerging Europe500 GlobalAsymmetry VenturesCivilization Ventures Management, Llce2vcFifty Years+24 more
Cartesian Therapeutics is a clinical-stage biotechnology company developing mRNA-based cell therapies aimed at treating autoimmune diseases.
BiotechHealthtechWatertown, US
Metin Kurtoglu(Executive Officer)Omid Farokhzad(Director)Chris Jewell(Executive Officer)inCarsten Brunn(President, CEO & Chairman of the Board)inEmily English(Executive Officer)inBlaine Davis(Executive Officer)in
Co-investorsK2 HealthVenturesMaryland TEDCOSchooner CapitalTEDCO+ND CapitalPolaris Partners+1 more
Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.
BiotechDeep TechMedical DevicesSouth San Francisco, US
Tim Lu(Co-Founder and Chief Executive Officer)inPhilip Lee(Executive Officer)inKanya Rajangam(President, Head of Research & Development and Chief Medical Officer)inYvonne Li(Executive Officer)inJames Collins(Director)Timothy Lu(Founder)
Co-investorsEvolution VC PartnersFlucas VenturesGaingelsGreen Sands EquityLifeforce CapitalLifeSci Venture Partners+14 more
21CM develops advanced biopreservation technologies, including vitrification and cryopreservation solutions, for preserving living systems ranging from mammalian cells to whole organs in biomedical research and clinical applications.
BiotechDeep TechFemTechHealthtechLongevityMedical DevicesFontana, US
Greg Fahy(Chief Scientific Officer)
San Francisco, US
Todd Huffman(Founder)Megan Klimen(Founder)
BoardJoshua Wolfe(Director)Matt Ocko(Director)inAdam Goulburn(Director)inAdam Goulborn(Director)
Co-investorsComet LabsDolby Family VenturesRecode VenturesDCVC (Data Collective)Dimension CapitalLux Capital+1 more
Activated Research Company (ARC), founded in 2014, develops chemical analysis detection technologies such as gas chromatography add-ons (Polyarc and Jetanizer) that improve data accuracy and sample throughput.
Deep TechHardwareNew Materials
Adámas manufactures nanodiamond materials and quantum sensing instrumentation for research and applications in life sciences, biomanufacturing, and nanocomposites.
BiotechDeep TechNew MaterialsQuantum Computing
Dr. Olga Shenderova(President, CTO)Dr. Gary McGuire(Director of Business Development)
BiotechAlameda, US
Michael D. West(President and CEO)Russell Skibsted(Chief Financial Officer)
BoardAlfred Kingsley(Chairman)Michael H. Mulroy(Director)
Quanterix (operating together with Akoya) develops biomarker measurement platforms that combine ultrasensitive blood/CSF liquid immunoassays with spatial tissue proteomics for research and clinical use in neurology, oncology, inflammation, cardiology and infectious disease.
BiotechDigital HealthMedical DevicesBillerica, US
Brian McKelligon(Executive Officer)Garry Nolan(Director)Matthew Winkler(Director)
BoardRob Hart(Executive Officer)inRobert Shepler(Director)inThomas Raffin(Director)in
Co-investorsaMoonStartXTelegraph Hill Partners
Alcamena Bio develops an AI-guided peptide discovery platform that combines computational design with high-throughput experimental screening to engineer therapeutic peptides, including those capable of crossing the blood-brain barrier for CNS targets.
AI & Machine LearningBiotechDeep Tech
Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).
BiotechHealthtechMedical DevicesAustin, US
Adam Berman(Executive Officer, Director)inJacob Kriegel(Executive Officer, Director)Avni Patel(Executive Officer, Director)Christopher Alex Arevalos(Executive Officer, Director)Albertien Greijdanus(Executive Officer, Director)
BoardGeoff Pardo(Director)in
Co-investorsBroadview VenturesRiverVest Venture PartnersTMC Venture FundCadence Healthcare VenturesGilde HealthcareGilmartin Capital LLC+3 more
Altis Biosystems builds RepliGut®, human intestinal tissue models grown from human intestinal stem cells that provide human-relevant preclinical data for drug absorption, metabolism, toxicity, and disease modeling.
BiotechDeep TechHealthtechMedical DevicesDurham, US
Christopher Sims(Executive Officer)inJimmy Smedley(Executive Officer)inSamuel Franklin(Director)Joseph McMahon(Director)Michael Biron(Executive Officer, Director)
BoardChristopher Perkins(Director)
Co-investorsAtlanta Technology AngelsCentral Texas Angel NetworkCheckmate Capital Group LLCCowtown AngelsHatteras Venture PartnersJohnson Venture Partners+2 more
BiotechLa Jolla, US
Gregory Hook(Co-Founder, Vice President Research and Corporate Counsel)inMichael D. Pierschbacher(President and Chief Executive Officer)
BoardBernice Welles(Director)J. Gregory Swendsen(Director)
CAMET (Curated Access to Model-based Engineering Tools) is a subscription library of model-based engineering and analysis plugins for system engineers and architects working on complex cyber-physical and embedded systems.
Deep TechDefense TechDeveloper Tools
HealthtechChantilly, US
Olivia Walch(Executive Officer, Director)Daniel Forger(Executive Officer, Director)
BoardMichael Masterson(Director)in
Co-investorsHealthX VenturesSupermoon CapitalInflect Health
Co-investorsConnecticut Innovations
BiotechResearch Triangle Park, US
Robert V. House(Executive Officer, Director, Promoter)Carl N. Kraus(Executive Officer, Director, Promoter)
BoardBarry Garfinkle(Director)Joe McMahon(Director)Joseph W. St. Geme(Director)
Autonomous Healthcare develops autonomous systems for intensive care unit patient monitoring and closed-loop drug delivery management.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Wassim M. Haddad(Co-Founder, Chairman of the Board, Chief Scientific Advisor)Behnood Gholami(Co-Founder, Chief Executive Officer)
Duality provides a platform using privacy-enhancing technologies—such as fully homomorphic encryption, federated learning, and trusted execution environments—that lets organizations analyze and collaborate on sensitive or distributed data and AI models without moving or exposing it.
AI & Machine LearningCybersecurityData & Infrastructure
Axcend builds compact, portable HPLC (high-performance liquid chromatography) instruments, including the Focus LC line with automated sampling, real-time reaction monitoring, and multi-wavelength UV detection.
BiotechDeep TechHardwareSalt Lake City, US
MILTON L LEE(MANAGER)GLEN D MELLA(CHIEF EXECUTIVE OFFICER)in
BoardBRANDON D FUGAL(MANAGER)CHRISTOPHER M LEE(MANAGER)
Co-investorsPartnership Capital Growth LLC
Behaivior is a digital health company using AI, behavioral health technology, and wearables to improve mental health recovery and crisis prevention for individuals at risk of addiction and mental health crises.
AI & Machine LearningCybersecurityDigital HealthHealthtechMental HealthPittsburgh, US
Ellie Gordon(Founder)in
Co-investorsTechstars
BiotechHouston, US
Sunil Sharma(Co-Chief Medical Officer)inJonathan P. Northrup(President/Secretary/Chief Executive Officer)inAlain Cappeluti(Chief Financial Officer)Stephen Horrigan(Chief Science Officer)inCasey Cunningham(Co-Chief Medical Officer)
BoardKenneth Carter(Director)
BioMojo develops AI-driven software–hardware systems, including a Human Digital Twin platform and XR-based immersive simulations, to model and optimize human sensorimotor, cognitive, and behavioral performance.
AI & Machine LearningDefense TechHealthtech
C2N Diagnostics develops blood tests for early detection of Alzheimer's disease and cognitive impairment by measuring brain-related biomarkers in patients aged 50+.
BiotechDigital HealthHealthtechMedical DevicesWashington University, US
Joel B. Braunstein(Co-Founder and CEO)David Holtzman(Scientific Co-Founder)Randall Bateman(Scientific Co-Founder)Ilana Fogelman(Co-Founder and Senior Advisor for Medical Innovation)
Cairn Biosciences is a drug discovery company that uses its COMPASS platform to map multiscale cell dynamics and simulate living biology in order to identify novel drug targets and therapeutics.
AI & Machine LearningBiotechHealthtech
Mary Ludlam(Founder & CEO)Payman Amiri(CSO)
Calder Biosciences develops protein-based subunit vaccines using its 3D-Vaxlock technology, which uses dityrosine crosslinking to lock immunogens into the shape they hold on a virus surface for improved antibody responses.
BiotechHealthtechMedical DevicesNYC, US
Christopher Marshall(Founder & CEO)inMark A. Yondola(Founder & Chief Science Officer)inDirk Pleimes(Chief Medical Officer)in
Co-investorsSOSV
CaliberMRI develops QA/QC automation software and imaging phantoms that standardize quantitative MRI calibration for research institutions, hospitals, and imaging centers.
AI & Machine LearningDeep TechHardwareHealthtechMedical DevicesBoulder, US
William Hollander(CEO & Founder)
care.coach is a digital health platform that serves elderly individuals and their caregivers through integrated technology, focusing on fall prevention, reducing emergency department visits, and addressing social isolation in Medicare and Medicaid populations.
Digital HealthHealthtechLongevityWellness & Fitness
Victor Wang
Co-investorsAARPStartUp HealthCartmell VenturesDaybreak PartnersThird Act VenturesBuenavista Equity Partners
CaroGen Corporation develops immunotherapies for cancer and infectious diseases based on an enveloped self-amplifying mRNA (virus-like vesicle) platform, with lead candidates including CARG-2020 for ovarian and other cancers and CARG-201 for hepatitis B.
BiotechHealthtechFarmington, US
Bijan Almassian(CEO)inValerian Nakaar(Chief Scientific Officer & Board Member)inDeborah Church(Chief Medical Officer)King Lee(VP, Regulatory Affairs)Timur Yarovinksy(VP, Discovery)Joseph Rininger(VP, Product Development)
Co-investorsConnecticut Innovations
Cenoxsys develops breakthrough medications with a focus on drug discovery and development for central nervous system diseases, pain, trauma, and inflammation.
AI & Machine LearningBiotechDeep TechHealthtechMonmouth Junction, US
Daniel E. Benjamin(CEO)Edwin Holland(COO)
BiotechSan Carlos, US
Ramkumar Mandalam(Executive Officer, Director)Stephen Greenberg(Director)Gisela Schwab(Director)Rodney Young(Executive Officer)Richard G. Rathmann(Director)Robby Hogle(Director)
BiotechPittsburgh, US
Eric T. Aherns(Director)Charles F. O'Hanlon, III(Executive Officer, Director)Lourdes M. Castellanos(Executive Officer)T. Ronald Casper(Executive Officer)Eric T. Ahrens(Director)
BoardL. Gerald Tarantino(Director)
Co-investorsPittsburgh Life Sciences Greenhouse
Centerline Biomedical develops IOPS®, a 510(k)-cleared endovascular navigation technology that provides real-time 3D image guidance for physicians performing catheterization and other endovascular procedures.
BiotechDeep TechHealthtechMedical DevicesCleveland, US
Vikash Goel(Executive Officer)inGulam Khan(Executive Officer, Director)inIndrani Egleston(Executive Officer)inPhil Rackliffe(Executive Officer, Director)inVinod K. Goel(Executive Officer)
BoardMichael Whitman(Director)
Co-investorsDevice of Tomorrow CapitalJobsOhio VenturesJumpstart Ventures
Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy.
BiotechDigital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)inRandall Stanicky(Executive Officer)inAnthony Costello(Director)Bruce Robertson(Director)Douglas Langa(Director)
BoardAlex Zisson(Director)
Co-investorsAccelmed PartnersH.I.G. CapitalH.I.G. HealthBridge PartnersHealth Catalyst CapitalHikma VenturesRevelation Partners+6 more
Cogentis discovers and develops first-in-class therapeutic treatments designed to prevent neurodegeneration and restore brain function for patients with conditions including frontotemporal dementia, Parkinson's disease, ALS, and Alzheimer's disease.
BiotechDeep TechLongevityMedical Devices
J. Kent Werner Jr.(Founder and CEO)
Consensus Networks offers a digital asset management dashboard that lets users aggregate and manage cryptocurrencies and NFTs across multiple blockchain protocols, including Ethereum.
Crypto & Web3Data & Infrastructure
Co-investorsElevate Ventures
San Diego, US
Anders Dale(Director)Chris Airriess(Executive Officer, Director)Guri Stark(Executive Officer, Director)Nathan White(Executive Officer, Director)Thomas Barich(Executive Officer)Paul Mirabella(Director)
BiotechSudbury, US
Ellen Cordo(Treasurer)Richard Smith(Secretary)James Jenson(Director, President and Chief Executive Officer)
DILIsym provides model-informed drug development (MIDD) software and consulting, covering ADMET prediction, PBPK, pharmacometrics, and QSP/QST for scientists and teams working across the drug development lifecycle.
AI & Machine LearningBiotechSaaS
DreamFace Technologies develops socially assistive robots powered by AI to support chronic care management and healthy aging for older adults.
AI & Machine LearningDigital HealthHealthtechRobotics
Eclipse Orthopaedics is developing the Radioscopic Targeting Attachment (RTA), a freehand targeting and drilling device to help surgeons perform distal locking during intramedullary nail fixation of leg and hip fractures with less operative time and reduced radiation exposure.
Advanced ManufacturingHardwareHealthtechMedical DevicesWarsaw, US
Barry W. Rich(Executive Officer, Director)David B. Rich(Executive Officer, Director, Promoter)
Co-investorsElevate VenturesFirst Leaf Capital
Eko develops FDA-cleared digital stethoscopes and AI-powered software that enables healthcare professionals to detect and diagnose cardiovascular disease with greater accuracy.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Connor Landgraf(Co-Founder and CEO)inTyler CrouchinJason Bellet(Co-Founder and Chief Business Officer)in
Co-investorsQuesta CapitalHighland Capital PartnersArtis VenturesBetter Ventures Central LlcCAL InnovationCalifornia Innovation Fund+16 more
Eliaz Therapeutics develops XGal-3, an investigational therapeutic apheresis device that uses an antibody-based resin to remove the protein Galectin-3 from the bloodstream.
BiotechHealthtechMedical DevicesSanta Rosa, US
Isaac Eliaz(Executive Officer, Director)Milton Goss(Executive Officer)
BiotechSan Francisco, US
Eva Martin(CEO, President, CFO, and Secretary)
BoardAndrew Perlman(Director)
Emulate builds Organ-on-a-Chip systems, including platforms, consumables, and pre-assembled BioKits with validated human cell models, to support drug discovery research.
BiotechDeep TechHealthtech
Donald Ingber(Founder)inDaniel Levner(Co-Founder & CTO)inJim Corbett(CEO, Board Member)inLorna Ewart(Chief Scientific Officer)in
Co-investors+ND CapitalNorthpond VenturesALS Investment FundAlumni VenturesAlwyn CapitalFourth Realm+5 more
Endoscopy Assist Devices designs medical devices that enhance endoscopy procedures, specifically polyp traps that improve workflow and specimen collection for healthcare professionals.
HealthtechMedical Devices
Enzyme by Design engineers modified enzymes for medical applications, with particular expertise in developing improved versions of therapeutic proteins like L-asparaginase for cancer treatment.
BiotechDeep TechHealthtechMedical DevicesChicago, US
Arnon Lavie(Co-founder, President, CEO, CSO, Director)Amanda M. Schalk(Co-founder, COO, NIH Grants PI, Director)Gary Gordon(Head of Clinical Development, Director)
Fibralign is a Stanford-spinout, commercial-stage company that develops therapeutic medical devices built on its Nanoweave collagen scaffolding technology for tissue engineering and regenerative medicine.
BiotechHardwareHealthtechMedical DevicesNew MaterialsUnion City, US
Greg Kingin
Co-investorsStartX
Fischer Imaging develops diagnostic imaging products, continuing a long-standing legacy in the medical imaging field.
HardwareHealthtechMedical Devices
Cell Microsystems develops laboratory instruments and platforms for cell engineering, culture, isolation, and analysis, including single-cell sorting, 3D cell culture, cell counting, tissue dissociation, and automated electrophysiology.
BiotechDeep TechHardware
Co-investorsClaremont Creek VenturesMission Bay CapitalMission BiocapitalSignet Healthcare PartnersWestern Technology Investment
Forcyte Biotechnologies develops drug screening tools that measure cell contractility to identify therapeutic candidates for diseases driven by abnormal cellular force generation, such as asthma, fibrosis, and hypertension.
HealthtechMedical DevicesLos Angeles, US
Ivan Pushkarsky(Founder)inDino Di Carlo(Founder)in
Co-investorsBVP InvestorsJude GomilaSprint VcY CombinatorAcequia Capital (AceCap)Asymmetry Ventures+3 more
Cerulean Scientific develops medical devices with a surface technology designed to resist clogging, obstruction, and biofouling, aimed at reducing device failure rates.
Deep TechHealthtechMedical DevicesLancaster, US
Andrew K Jones(Executive Officer, Director)Daniel C Hobson(Executive Officer, Director)
BiotechResearch Triangle Park, US
Amanda Elam(Executive Officer, Director)Edward Breitschwerdt(Director)Ricardo Maggi(Director)B. Jefferson Clark(Executive Officer, Director)Nicole Bell(Executive Officer, Director)
BoardRichard West(Director)
Co-investorsArieal Southeast Angel PartnersBoston Harbor AngelsWisconsin Investment Partners
Gateway Pharm develops a delayed-release metronidazole capsule formulation for treating Clostridioides difficile infections, a leading cause of hospital-associated gastrointestinal illness.
BiotechDigital HealthHealthtechMedical DevicesSt. Louis, US
Lianli Li(Founder and President)
GMS Biotech develops diagnostics and therapeutics solutions, leveraging expertise in biotech commercialization and intellectual property management.
BiotechHealthtechMedical Devices
Krishna Jayaraman(CEO & Co-Founder)Melissa D. Schwaller(VP of Intellectual Property)
Co-investorsSand Hill Angels
Global Instrumentation designs and manufactures medical devices and digital platforms for cardiac monitoring and electrocardiology, serving healthcare providers and patients globally.
Digital HealthHardwareHealthtechMedical Devices
Jim DeMaso(President)Craig Sellers(Vice President, Regulatory Affairs)Scott Myers(Vice President, Operations & Program Management)
GreenMark develops non-invasive dental products for dentists, hygienists, and patients that treat tooth sensitivity and support oral health management.
BiotechHealthtechMedical DevicesEast Lansing, US
Steven Bloembergen, PhD(Executive Officer, Director)Steven Bloembergen(Executive Officer, Director)
BoardMichael Snyder(Director)Joerg Lahann, Ph.D.(Director)Kenneth Pienta(Director)Frank van Luttikhuizen(Director)
Co-investorsID VenturesInvest MichiganMichigan Rise
HabitAware makes Keen2, a vibrating awareness bracelet paired with recovery coaching and an online community to help people manage body-focused repetitive behaviors such as hair pulling, skin picking, and nail biting.
Digital HealthMental HealthWellness & FitnessSaint Louis Park, US
Aneela Idnani(Executive Officer, Promoter)Kirk Klobe(Co-founder & CTO)Sameer Kumar(Co-founder & CEO)John Pritchard(Co-founder & Lead Hardware Engineer)Aneela Idnani Kumar(Co-founder & Designer)
Co-investorsBackstage CapitalSOSV
hc1 offers hc1 IQ, an AI-based platform that turns laboratory and diagnostic data into clinical, operational, supply chain, and market-growth intelligence for health systems and providers.
AI & Machine LearningDigital HealthHealthtech
Bradley Bostic(Chairman and CEO)in
Co-investorsA1 Health VenturesElevate Ventures
HealthMyne develops QIDS, a quantitative imaging and clinical decision support platform for oncology care teams that tracks incidental findings, supports tumor conference preparation, and provides quantitative imaging metrics such as lesion volume and texture analysis.
AI & Machine LearningDigital HealthHealthtechMedical DevicesMadison, US
Roger Chylla(Executive Officer, Director)inHao Wang(Executive Officer)inPraveen Sinha(Executive Officer, Director)inArvind Subramanian(Executive Officer, Director)inThomas Rockwell Mackie(Director)
BoardGreg Robinson(Director)
Co-investorsAlumni VenturesAscension VenturesBascom Ventures4490 Ventures
i3 develops a hybrid intravascular imaging catheter combining near-infrared fluorescence (NIRF) and ultrasound (IVUS) sensors to provide real-time molecular and structural imaging during coronary interventions.
AI & Machine LearningDeep TechHealthtechMedical DevicesBoston, US
Co-investorsBroadview Ventures
Immusoft develops a cell therapy platform called Immune System Programming (ISP) that engineers a patient's B cells into plasma cells that produce therapeutic proteins after being infused back into the patient.
BiotechDeep TechHealthtechSeattle, US
Matthew Scholz(Founder)inSean Ainsworth(Chief Executive Officer)inRobert Sikorski(Chief Medical Officer)Rob Hayes(Chief Scientific Officer)inScott McIvor(Chief Development Officer)Eric Garcia(Executive Officer)in
Co-investorsBioRock VenturesBoston Harbor AngelsBreakout VenturesEQx FundInvariantes FundMichigan Capital Network+7 more
Immvention Therapeutics develops first-in-class BACH1 inhibitors intended as an oral therapy for patients with sickle cell disease and other conditions.
BiotechDigital HealthChapel Hill, US
Jenny Ting(Director and Co-founder)Matthew Cohen(Director)Lev Osherovich(Director)Mark Vellaca(Director)Anil Goyal(CEO and Director)
BoardBenjamin Scruggs(Director)
Co-investorsDelin VenturesHatteras Venture PartnersOUP (Osage University Partners)
Imtherapeutics develops oral therapies for Type 1 diabetes patients with specific genetic markers.
Biotech
Co-investorsJDRF T1D Fund
ingenious targeting laboratory (iTL) is a U.S.-based company that generates genetically engineered mouse models for biomedical research institutions and pharmaceutical companies.
BiotechDeep TechHealthtechHolbrook, US
Jennifer Parla(Dr.)Milen Kirilov(Dr.)Arielle Bryan(Dr.)
Inimmune is a clinical-stage biotech company developing immunotherapies for allergy, cancer, infectious, and autoimmune diseases.
AI & Machine LearningBiotechDeep TechHealthtechWhitefish, US
Jay EvansinDavid BurkhartinHelene Bazin-LeeinKendal Ryterinalan joslynin
Co-investorsTwo Bear Capital
BiotechPortola Valley, US
Lena Wu(Executive Officer, Director)Erik Gentalen(Director)Michael Rubin(Director)
BoardJenny Rooke(Director)in
Co-investorsHemisphere Ventures LLCVertical Venture PartnersGenoa VenturesNorthpond Ventures
Isolere Bio develops affinity-based reagents and purification platforms for concentrating and purifying viral vectors used in gene therapy, including adeno-associated viruses and lentiviruses.
Advanced ManufacturingBiotechDeep TechNew MaterialsResearch Triangle Park, US
Michael LaBreck(Co-founder)Michael Dzuricky(Director of Advanced R&D)
Co-investorsNorthpond Ventures
Karamedica develops chitosan-based biomedical technologies for therapeutic applications, particularly focused on Alzheimer's disease and drug delivery systems.
AI & Machine LearningBiotechHealthtechMedical DevicesNew Materials
Andrew Crofton(Chief Executive Officer)Samuel Hudson(Chief Scientific Officer)Taub T Swartz(Chief Financial Officer)
Kinto provides personal care coaching to family caregivers looking after a loved one with dementia, pairing them with a designated Care Coach and offering a curriculum with personalized action plans.
Digital HealthHealthtechWellness & Fitness
Co-investorsThe E14 FundBrevan Howard Digital
Kromatid provides single-cell structural genomic analysis tools for cell and gene therapy companies, enabling assessment of genomic integrity and identification of complex structural rearrangements during therapy development.
AI & Machine LearningBiotechDeep TechMedical DevicesLongmont, US
Andrew Jost(Executive Officer)James Chomas(Executive Officer, Director)Christopher Tompkins(Executive Officer, Director)Susan Bailey(Executive Officer)Joel Bedford(Director)
BoardTerry Opgenorth(Director)
Co-investorsBroadOak Capital Partners
Kuda Therapeutics develops novel cancer therapies targeting hypoxia and HIF signaling pathways.
BiotechHealthtechLongevityMedical DevicesSalt Lake City, US
Dr. Mei Yee Koh(Founder/Director and Chief Executive Officer)Mr. Travis Ehlinger(co-Founder/Director and Chief Financial Officer)
Leuko develops a noninvasive white blood cell monitor to track neutropenia risk in cancer patients and others undergoing treatment.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBoston, US
Ian Butterworth(Chief Technology Officer)inAurelien Bourquard(Chief Data Scientist)inAlvaro Sanchez-Ferro(Chief Medical Officer)inCarlos Castro-Gonzalez(Founder)inPaul Hartung(Director)in
BoardAmy Salzhauer(Director)in
Co-investorsGood Growth CapitalDorm RoomMassVenturesNina CapitalIAG Capital Partners
Lumen Bioscience develops orally and intranasally delivered biologic drugs and protein-based nutrition products using genetically engineered spirulina algae to express therapeutic proteins such as antibodies, enzymes, and cytokines.
BiotechDeep TechHealthtechSeattle, US
Erik Anderson(Director)Mark Litton(Director)Robert Carlson(Director)Craig Behnke(Executive Officer)Ed Schlect(Director)John Morrow(Executive Officer)
Co-investorsSamsara BioCapital
Lyssn provides AI-powered tools for behavioral health and child welfare organizations to reduce staff burnout and improve implementation of evidence-based practices.
AI & Machine LearningDigital HealthHealthtechMental HealthSaaSSeattle, US
Zachary E. Imel(Director, Promoter)David C. Atkins(Executive Officer, Director, Promoter)inMichael J. Tanana(Director, Promoter)in
BoardSeth Feuerstein(Director)
Madorra develops a nonhormonal, noninvasive medical device to treat vaginal dryness and vulvovaginal atrophy, targeting post-menopausal people and breast cancer survivors.
FemTechHealthtechMedical DevicesPortland, US
Co-investorsAvestria VenturesBerkeley CatalystOneVenturesPortfoliaPortland Seed FundSocial Starts+2 more
Managed Health Connections develops digital health solutions and customizable research platforms that support substance use disorder treatment, contingency management, screenings, and cognitive impairment tools, integrating with academic and EHR systems.
AI & Machine LearningDigital HealthHealthtech
Kim Johnson(Co-Founder & CEO)Carol Johnson(Co-Founder & CFO)
Manhattan BioSolutions develops targeted biologic agents for treating orphan diseases and areas with unmet medical need.
BiotechDeep TechEnterprise SoftwareHealthtechMedical Devices
Mr. Mohr(Co-founder, BioAsset Advisors)David Yu(Strategic Advisor)John PsaltosBobRonald T. Raines(Firmenich Professor of Chemistry, MIT)
Materna Medical develops medical technologies to address pelvic health needs in obstetrics and gynecology.
FemTechHealthtechMedical DevicesMountain View, US
Tracy MacNeal(Chief Executive Officer)in
BoardAriella Golomb(Director)Peter Wyles(Director)Arthur Reidel(Director)Jim Bochnowski(Director)Patrick Jamp(Director)
Co-investorsAzure Ventures GroupBand of AngelsCitrine AngelsGaingelsHouston Angel NetworkTexas HALO Fund+2 more
MDI Therapeutics is a pharmaceutical company developing small molecule therapies for fibrosis and fibroproliferative diseases, including MDI-2517, an inhibitor of plasminogen activator inhibitor 1 (PAI-1) currently in a Phase 1 clinical study.
BiotechHealthtechNovi, US
Duane Day(Executive Officer, Director)Stephen Benoit(Executive Officer, Director)inDaniel Lawrence, Ph.D.(Executive Officer, Director)
Powell, US
Brett P. Thornton(Executive Officer)Gary J. Ross(Executive Officer, Director)
BoardDavid Bergeron(Director)
Co-investorsRev1 Ventures
A retailer of inspirational and religious merchandise including apparel, gifts, home décor, and media products sourced from multiple brand partners.
Consumer
Co-investorsSlater Technology Fund
Meridian Biotech develops fermentation-based technologies that upcycle low-value by-products from fermentation industries into multi-functional feed ingredients.
AgTechBiotechFoodTech
Targeting mitochondria for neurodegenerative disease therapies.
BiotechNew York, US
Nicholas Hertz(Director)Doug Crawford(Director)Daniel de Roulet, Jr.(Executive Officer, Director)
BoardJohannes Fruehauf(Director)
Co-investorsMission Bay CapitalMission BiocapitalPfizer Venture Investments
N8 Medical is a clinical-stage medical device company developing CeraShield, a coating based on antimicrobial compounds called Ceragenins that is applied to indwelling medical devices and implants to prevent hospital-acquired infections.
BiotechHealthtechMedical Devices
NanoMedTrix develops and manufactures nanoparticles for medical applications, particularly targeted cancer therapies that combine diagnostic imaging with drug delivery.
BiotechDeep TechMedical DevicesIowa City, US
Joe Assouline(Founder and Chief Science Officer)Sean Sweeney(Director of Engineering and Manufacturing)
BiotechHealthtechOregon City, US
Neil Roundy(Executive Officer, Director, Promoter)Rachel Dreilinger(Executive Officer, Director, Promoter)Coni Rosati(Director, Promoter)
BoardMichael Tippie(Director)
Neurodon develops small-molecule therapeutics that target cellular calcium imbalance and the endoplasmic reticulum stress pathway, using compounds that allosterically modulate the SERCA enzyme to restore calcium transport.
BiotechHealthtechCrown Point, US
Russell Dahl(Executive Officer, Director)Brunde Broady(Founder)in
Co-investorsElevate Ventures
Nokomis develops ADEC, a non-invasive diagnostic system that detects counterfeit, defective, and maliciously modified electronic components and circuit boards by analyzing their unintended radio frequency emissions.
Advanced ManufacturingCybersecurityDeep TechDefense TechHardwareCharleroi, US
NovoPyxis applies mathematics and physics principles, including knot theory and fluid dynamics, to drug design and delivery, predicting protein structures of uncrystallized targets and designing peptide agonists.
BiotechDeep TechMedical DevicesCambridge, US
Daniel Vannoni(Director)Raja Srinivas(Director)inMadhavi Gavini(Executive Officer, Director)
Co-investorsBantam Group
NuShores Biosciences is a medical device company developing first-to-market technologies, with a focus on bone and tissue regeneration and joint replacement applications.
BiotechHealthtechMedical DevicesNew MaterialsLittle Rock, US
Alexandru S. Biris(Co-Founder & CTO)inAndrew G. Kumpuris(Founder and Advisor)David E. Anderson(Founder and Advisor; co-founder)inSharon Ballard(Executive Officer, Director)Alex S. Biris(Founder / CTO)
4Saliva provides custom product development services for saliva collection kits and diagnostic testing tools, partnering closely with clients from design through manufacturing and assembly.
Advanced ManufacturingBiotechDigital HealthHealthtechMedical Devices
Oculogica develops FDA-cleared concussion assessment devices that use proprietary eye-tracking technology to measure abnormal eye movements caused by traumatic brain injury.
BiotechDigital HealthHealthtechMedical DevicesNew York, US
Rosina Samadani(Executive Officer, Director)Uzma Samadani(Director)inRobert Ritlop(Executive Officer)Pratipatti Laxminarain(Director)
BoardJill Enos(Director)inKathryn Swintek(Director)in
Co-investorsColle Capital PartnersSeraph GroupSoutheast Minnesota Capital FundStartXTitletownTechGolden Seeds+1 more
Osteocentric develops orthopedic implant systems for bone fixation, including fasteners, plates, and surgical instruments that use UnifiMI mechanical integration technology.
BiotechHardwareHealthtechMedical DevicesAustin, US
Co-investorsJStar Capital Investments
Oxalo Therapeutics is a preclinical-stage biopharmaceutical company developing therapies to treat and prevent diseases caused by hyperoxaluria and hyperoxalemia, such as recurrent calcium oxalate kidney stones.
BiotechHealthtechChicago, US
Yang Zheng(Co-founder, Business lead)inHatim Hassan(Co-founder, R&D lead)
OyaGen is a preclinical drug discovery and development company that identifies and optimizes lead compounds as investigational new drugs for infectious diseases and cancer, then licenses or partners them with industry leaders for clinical development.
BiotechDeep TechHealthtechRochester, US
Harold C. Smith(Founder)inRyan P. Bennett(CSO & Laboratory Director)Richard McCloskey(Director)Thomas Fitzgerald(Chief Operations Officer)Richard Ogden(Director)Roscoe Moore(Director)
BiotechKennett Square, US
Frank Minella(Executive Officer, Director)inAlexander Ruckdaeschel(Executive Officer, Director)
BoardJohn H. Stewart(Director)Andrew Koopman(Director)
Co-investorsDelaware Crossing Investor GroupItalian Angels for GrowthNYU Innovation Venture Fund
Pendar Technologies develops Raman spectroscopy instruments and autonomous chemistry systems for chemical analysis and discovery, including handheld devices for identifying threat materials and tools for real-time reaction kinetics, inspection, authentication, and process control.
Deep TechDefense TechHardware
PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.
BiotechHealthtechMedical DevicesMalvern, US
Ashutosh Chilkoti(Director)Joel Sussman(Executive Officer)Jonathan Mow(Chief Executive Officer)in
BoardJames Barrett(Director)Michael Gutch(Director)Justin Klein(Director)
Co-investorsMountain Group CapitalNew Enterprise Associates (NEA)Hatteras Venture PartnersJohnson & Johnson Innovation – JJDC
Point Designs manufactures the Point Digit, a heavy-duty mechanical prosthetic finger designed for individuals with finger loss, featuring a patented ratcheting mechanism that locks into multiple positions for independent finger control.
HardwareHealthtechMedical Devices
Potentiometric Probes develops voltage-sensitive fluorescent dyes (VSDs) that let researchers visualize electrical activity in cells, tissues, and organs such as the brain and heart via microscopy.
BiotechDeep TechMedical Devices
Leslie Loew(Co-Founder)
Precision Membranes designs and manufactures reverse osmosis membranes built around a proprietary internal geometry and manufacturing platform intended to improve flow, reduce pressure loss, and lower energy use while keeping the same external drop-in format.
CleantechDeep TechNew Materials
Primetime Life Sciences develops mutual prodrugs that combine existing approved small molecule drugs to improve therapeutic efficacy, safety, and pharmacokinetic characteristics while reducing development time and cost.
BiotechHealthtechLongevityMedical Devices
Prokaryotics is a preclinical antibacterial discovery company developing new classes of antibiotics that target bacterial cell envelope biogenesis to combat multidrug-resistant Gram-negative and Gram-positive bacteria.
BiotechDeep TechHealthtech
Terry Roemer(Founder & CSO)
Co-investorsMPM BioImpactVida Ventures
Protein Foundry develops molecular tools and production services for chemokines, with expertise in preserving native protein sequences for biological activity.
BiotechDeep TechMilwaukee, US
Dr. Brian F. Volkman(President)Dr. Francis C. Peterson(Vice President)Dr. Michael B. Dwinell(Vice President)
Quantitative BioSciences develops biosensor and immunoassay solutions using microfluidics, synthetic biology, and machine learning for scientific research and government applications.
AI & Machine LearningBiotechDeep TechHardware
Natalie Cookson(Co-founder & CEO)Michael Ferry(Co-founder & CSO)
Reia Health manufactures a collapsible medical-grade silicone pessary for treating pelvic organ prolapse in women, designed for self-insertion and removal at home.
FemTechHealthtechMedical Devices
Kaitlin Maier(CEO)Ariana Sopher(COO)Meegan Daigler(CTO)Paul Hanissian(CMO)
Results Group is a research organization that translates research into solutions and operates Motive Labs, working with university and government research collaborators including NIH, NIDILRR, DHA, CDMRP, MTEC, and the UK NHS-HRA.
Deep TechDefense TechHealthtech
RevBio develops a biomimetic bone adhesive platform derived from marine biology for bone repair and regenerative applications across dental, orthopedic, and neurosurgical indications.
BiotechHealthtechMedical DevicesNew MaterialsLowell, US
Brian Hess(Chief Executive Officer, Founder)inD. GRAYSON ALLEN(Executive Officer, Director)in
BoardKEVIN FOLEY(Director)GEORGE KAY(Director)
Co-investorsArieal Southeast Angel PartnersBeacon AngelsBoston Harbor Angels
Rithim Biologics develops surgical delivery instruments and gene therapies to treat cardiac arrhythmias, including atrial and ventricular rhythm disorders.
BiotechHealthtechMedical DevicesWorcester, US
J. Kevin Donahue(Co-Founder)Ronald L. Anderson
RTC Electronics makes the iPecs Lab, a fully integrated wireless load cell and data logger that measures 3 forces and 3 moments across 6 degrees of freedom, with onboard signal conditioning, data logging, and user-selectable sampling rates.
Deep TechHardwareIoT
SafeTraces develops technology to measure and verify indoor air quality and ventilation performance, aimed at ensuring air safety in indoor environments.
BiotechCleantechDeep TechHardwareHealthtechPleasanton, US
Ulrike Hodges(Director)Antonios Zografos(Executive Officer, Director)John Kraus(Director)Rob Veres(Director)
Co-investorsAgility CapitalCity LightS2G InvestmentsBungeOmidyar Network
SealCath develops the Cephus Catheter, a rectal catheter with dual inflatable balloons designed to instill air or fluid into the colon while creating an airtight seal.
HardwareHealthtechMedical DevicesMount Pleasant, US
Dr. Cephus E. Simmons, Sr.(Founder and CEO)Cephus E. Simmons(Founder and CEO)
Sensimetrics develops software and hearing aid signal processing technologies for individuals with hearing impairment, including noise-reduction algorithms, hearing loss simulations, and assistive listening devices.
AI & Machine LearningDeep TechHardwareHealthtechMedical DevicesCambridge, US
Patrick M. Zurek(President)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
























__Twitter.png)






















.png)






































.png)




















































































































